Literature DB >> 881279

Pharmacological evaluation of YC-93, a new vasodilator, in healthy volunteers.

T Seki, T Takenaka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 881279

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Biopharm        ISSN: 0340-0026


× No keyword cloud information.
  15 in total

1.  The effects of verapamil on cerebrospinal fluid pressure in surgical patients.

Authors:  T Nishikawa; A Namiki
Journal:  J Anesth       Date:  1987-09-01       Impact factor: 2.078

2.  Blockade of slow calcium channels and regulation of circulatory pressor responses in uncomplicated hypertension.

Authors:  B Silke; R C Ahuja; R C Okoli; G I Nelson; S H Taylor
Journal:  Ir J Med Sci       Date:  1983-10       Impact factor: 1.568

3.  Haemodynamic dose-response effects of i.v. nicardipine in coronary artery disease.

Authors:  B Silke; S P Verma; G I Nelson; M Hussain; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

4.  The effect of acute and chronic nicardipine therapy on forearm arterial haemodynamics in essential hypertension.

Authors:  J Levenson; A C Simon; J Bouthier; B C Maarek; M E Safar
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

5.  The effect of slow-release nicardipine on ambulatory and clinic blood pressure in mild hypertension.

Authors:  J P Cox; J Ryan; E O'Brien; K O'Malley
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

6.  Effects and interaction of nicardipine and volatile anesthetics in the rat heart-lung preparation.

Authors:  Satoshi Kashimoto; Toshihiro Nakamura; Masaki Kume; Akihiko Nonaka; Teruo Kumazawa
Journal:  J Anesth       Date:  1994-03       Impact factor: 2.078

7.  Potentiation of the cardiovascular effects of nicardipine by enflurane anesthesia in canine blood-perfused heart preparations.

Authors:  M Manabe; S Motomura; T Kumazawa; K Hashimoto; T Kanbara
Journal:  J Anesth       Date:  1992-04       Impact factor: 2.078

8.  Inhibitory effect of uraemia on the hepatic clearance and metabolism of nicardipine.

Authors:  J H Ahmed; A C Grant; R S Rodger; G R Murray; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

9.  Cardiovascular, baroreflex and humoral responses in hypertensive patients during nicardipine therapy.

Authors:  P Coruzzi; A Biggi; L Musiari; C Ravanetti; A Novarini
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 10.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.